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Abstract
2020 by the authors. Licensee MDPI, Basel, Switzerland. Allergic diseases are the most common chronic
illness in childhood. Findings from developed countries have reported associations between Vitamin D
levels during pregnancy and offspring allergy risk. This prospective cohort study aimed to determine the
associations between maternal Vitamin D levels during late pregnancy and allergic diseases in Malaysian
infants during the first year of life. Serum 25(OH)D concentrations of 380 pregnant women in the third
trimester were measured using a chemiluminescent immunoassay. Children's allergic outcomes were
assessed at 3, 6, and 12 months based on parental reports. Specific IgE antibodies against food and
inhalant allergens were measured in infants at 12 months of age. A total of 43.2% pregnant women were
Vitamin D deficient (<30 nmol>/L) and 56.8% were nondeficient (≥30 nmol/L). A total of 27.6% of the
infants had eczema, 6.1% had wheeze, 27.4% had food sensitization, 10.8% had inhalant allergen
sensitization, and 3.8% had IgE-mediated food allergy during the first year of life. Compared with the
nondeficient group, maternal Vitamin D deficiency in late pregnancy was not associated with any allergic
outcomes after adjustment for potential confounding factors. In conclusion, the present study does not
support an association between maternal Vitamin D levels in late pregnancy and allergic outcomes during
the first year of life.
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Abstract: Allergic diseases are the most common chronic illness in childhood. Findings from
developed countries have reported associations between Vitamin D levels during pregnancy and
offspring allergy risk. This prospective cohort study aimed to determine the associations between
maternal Vitamin D levels during late pregnancy and allergic diseases in Malaysian infants during
the first year of life. Serum 25(OH)D concentrations of 380 pregnant women in the third trimester
were measured using a chemiluminescent immunoassay. Children’s allergic outcomes were assessed
at 3, 6, and 12 months based on parental reports. Specific IgE antibodies against food and inhalant
allergens were measured in infants at 12 months of age. A total of 43.2% pregnant women were
Vitamin D deficient (<30 nmol/L) and 56.8% were nondeficient (≥30 nmol/L). A total of 27.6% of the
infants had eczema, 6.1% had wheeze, 27.4% had food sensitization, 10.8% had inhalant allergen
sensitization, and 3.8% had IgE-mediated food allergy during the first year of life. Compared with
the nondeficient group, maternal Vitamin D deficiency in late pregnancy was not associated with any
allergic outcomes after adjustment for potential confounding factors. In conclusion, the present study
does not support an association between maternal Vitamin D levels in late pregnancy and allergic
outcomes during the first year of life.
Keywords: 25-hydroxyVitamin D; pregnancy; allergic diseases; sensitization; infant

1. Introduction
Allergic diseases are the most common chronic illnesses in childhood and about 60% of allergies
appear during first year of life [1]. Eczema and food allergy usually co-exist in early life, and eczema
was proposed as an “entry point” for subsequent allergic diseases such as asthma and allergic rhinitis [1].
The global prevalence of allergic diseases has increased dramatically in recent decades and have
Nutrients 2020, 12, 2418; doi:10.3390/nu12082418
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affected about 20% of the world’s population [2]. The prevalence of allergic diseases including eczema,
wheeze, and asthma, which were previously on the rise, have reached a plateau, or even started to
decrease in some developed countries [3–5]. Conversely, emerging evidence shows that allergic disease
prevalence, which was previously low, in developing countries continues to rise [6]. Development
of eczema and food allergy early in life tends to increase the likelihood of developing other atopic
diseases including asthma and allergic rhinitis in later childhood [1]. Apart from impaired quality
of life, allergic diseases also place a profound social and financial burden on patients, their families,
and society [2]. It is therefore important to identify the potentially modifiable risk factors of allergic
diseases, so that early preventive measures can be taken.
The development of allergic diseases can be explained through the complex interplay between
genetic inheritance and environmental exposures [2]. Although part of the increasing prevalence
of allergic diseases in childhood can be explained by genetic predisposition, increased attention has
been focused on the role of early life nutrition during the first 1000 days of life [7]. As diet is a
modifiable risk factor, targeting the role of early life nutrition in the development of allergic diseases
in children is essential for identifying potential primary prevention strategies. Vitamin D deficiency
is one of the common micronutrient deficiencies during pregnancy [8]. Vitamin D, which has long
been recognized for its importance in musculoskeletal health, has gained increased attention in recent
years for its role in nonskeletal outcomes such as allergic diseases [9]. Findings from several birth
cohorts suggested that maternal Vitamin D levels might play a role in the development of childhood
allergic diseases [10–12]. During pregnancy, the fetus is totally dependent on the mother for an
adequate supply of Vitamin D. Vitamin D in the fetus acquired from its mother through the placenta
can affect immune development and subsequent risk of childhood allergy [13]. While findings from
two birth cohorts revealed that a high maternal Vitamin D level is protective against childhood eczema,
food allergy, and wheezing [10,12], others have shown that it is a risk factor for eczema and food
allergy [11,14] or found no association [15]. Contradictory to the findings found in cohort studies,
recent randomized controlled trials (RCTs) of Vitamin D supplementation in pregnancy have not
proven to be effective against childhood allergies including eczema, food sensitization, wheeze, and
asthma [16–20]. Results from previous studies have been controversial and most of these studies were
conducted in developed countries. Therefore, more studies are needed to determine the role of Vitamin
D levels during pregnancy in allergic diseases, especially in developing countries.
Despite the abundance of sunlight in Malaysia, a tropical country located right next to the equator,
a high prevalence of Vitamin D deficiency has been reported among Malaysian pregnant women [21].
Considering the potential associations between maternal Vitamin D levels and allergy risk in children
as reported in previous studies, Malaysian infants born to mothers with low Vitamin D levels during
pregnancy might be at risk of allergy development. In view of the scarcity of prevalence data for
childhood allergic diseases in Malaysia and that currently no study has examined their associations
with maternal Vitamin D levels in this country, this study aims to determine the associations between
maternal Vitamin D levels and the development of allergic diseases in infants during the first year
of life.
2. Materials and Methods
2.1. Study Design and Study Population
This is a prospective cohort study conducted among pregnant women in late pregnancy
participating in the Mother and Infant Cohort Study (MICOS) [22]. The protocol of the study
and sample size calculation was previously described [22]. Between November 2016 and January 2018,
the original cohort of 557 pregnant women was recruited at government Maternal and Child Health
(MCH) clinics located in the state of Selangor and the Federal Territory of Kuala Lumpur, Malaysia.
Participating pregnant women and their children were then followed up prospectively at 3, 6, and
12 months postpartum. The inclusion criteria were ≥18 years of age, gestation age ≥ 28 weeks at time
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of recruitment, singleton pregnancy, and receiving antenatal care at the selected clinics. The exclusion
criteria were multiple pregnancies, delivery before 37 weeks of gestation, maternal immune deficiency,
and fetal congenital anomalies. The study was approved by the Ethics Committee for Research
Involving Human Subjects, Universiti Putra Malaysia [FPSK(FR16)P006] and the Medical Research
and Ethics Committee, Ministry of Health Malaysia (NMRR-16-1047-30685). Written informed consent
was obtained from all respondents.
2.2. Serum 25-Hydroxyvitamin D [25(OH)D] Analysis
Maternal serum 25(OH)D concentrations were measured once in late pregnancy. As detailed
previously [22], a venous blood sample (2 mL) was collected from pregnant women during their routine
antenatal check-up by trained nursing staff at the health clinics. When their blood was collected, the
gestational age of the pregnant women was recorded. The blood sample was transferred to the blood
collection tube and stored in the container provided by the laboratory at 2–8 ◦ C. Blood samples were
then sent to the laboratory (Pantai Premier Pathology Sdn. Bhd., Kuala Lumpur, Malaysia) within 24 h
for further analysis. At the laboratory, the blood samples were analyzed by the trained laboratory staff
using the Siemens ADVIA Centaur Vitamin D Total assay (Siemens, Tarrytown, NY, USA) to determine
the serum 25(OH)D concentration. This assay has been standardized to the University of Ghent
ID-LC/MS/MS reference measurement procedure and certified by the CDC Vitamin D Standardization
Certification program [23]. Maternal serum 25(OH)D levels were categorized as deficient (<30 nmol/L)
and nondeficient (≥30 nmol/L) [24]. Results of the serum 25(OH)D analysis were given to the mothers
during the first postnatal follow-up at 3 months postpartum.
2.3. Allergic Sensitization
A peripheral venous blood sample of 1–2 mL was withdrawn via venepuncture in the dorsum of
an infant’s hand by a trained medical assistant at the health clinic at 12 months follow-up. The blood
sample was transferred into a serum separator tube and stored in the container provided by the
laboratory at 2–8 ◦ C. Blood samples were sent to the laboratory (Acutest Systems (M) Sdn. Bhd., Kuala
Lumpur, Malaysia) within 24 h from the time of specimen collection for processing. The allergen-specific
immunoglobulin E (IgE) levels against a panel of 19 types of food allergens (egg yolk, egg white,
soybean, peanut, milk, clam, crab, shrimp, codfish, tuna, salmon, wheat, chicken, beef, rice, banana,
orange, sesame seed, chocolate) and 16 types of inhalant allergens (house dust, Dermatophagoides farinae,
Dermatophagoides pteronyssinus, Blomia tropicalis, Timothy grass, Bermuda grass, mucor, Alternaria,
Aspergillus, Candida, Cladosporium, Penicillium, dog dander, cat dander, cockroach mix, and latex) were
analyzed by the trained laboratory staff using the OPTIGEN Allergen Specific IgE Assay (Hitachi
Chemical Diagnostics, Inc., Mountain View, CA). A level of specific IgE < 27 LU was rated as class 0,
27–65 LU as class 1, 66–142 LU as class 2, 143–242 LU as class 3, and >242 LU as class 4, respectively.
Infants with a specific IgE level of class ≥ 1 were defined as having sensitization [25].
2.4. Allergic Outcomes
Allergic outcomes including eczema, IgE-mediated food allergy, and wheezing in infants were
assessed at age 3, 6, and 12 months by trained researchers through face-to-face interviews with the
mothers. Eczema was defined according to the UK Working Party’s Diagnostic Criteria for Atopic
Dermatitis, namely having an itchy skin condition and fulfilling two or more of the following criteria:
(i) family history of allergic disease; (ii) history dry skin; (iii) history of involvement of skin creases;
and (iv) visible flexural eczema [26]. Infants with parent-reported food allergy symptoms who had
a specific IgE level of class ≥ 1 to a specific food allergen were defined as having IgE-mediated
food allergy. Food allergy symptoms were based on convincing clinical history that encompassed
three of the following criteria: (i) parent reporting at least one recognized allergic symptom, which
included localized symptoms (such as itching, sting/burning of the lips/mouth/throat, urticaria/hives,
angioedema), abdominal symptoms (such as nausea, vomiting, crampy/colicky abdominal pain,
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diarrhea), respiratory symptoms (such as wheeze, stridor, watery rhinitis, redness of eyes/nose), skin
symptoms (such as urticaria, itching, flushed skin, worsening eczema), or systemic reactions (such
as anaphylaxis, syncope); (ii) parent reporting a temporal relationship of a reaction, with symptoms
occurring within 2 h of food ingestion; and (iii) symptoms repeated each time the same food was
consumed [2]. Wheeze was defined as the parental report of infants who had wheezing or whistling
in the chest during the first year of life using the International Study of Asthma and Allergies in
Childhood (ISAAC) questionnaire [27].
2.5. Covariates
Information on potential confounders associated with allergic outcomes [28] was collected.
Information on maternal age, work status, ethnicity, educational level, maternal gestational age at
blood withdrawal, parity, gestational age at delivery, birth weight, mode of delivery, and infant sex were
obtained from clinic records. Meanwhile, information on monthly household income, maternal use of
antibiotics during pregnancy, number of siblings, pets at home during the first year, infants’ daycare
attendance during the first year, infant antibiotic use during the first year, exclusive breastfeeding, and
family history of allergic disease were obtained via face-to-face interviews with the mothers. Family
history of allergic disease was defined as any of the infant’s first-degree relatives having one or more
histories of eczema, food allergy, asthma or allergic rhinitis.
2.6. Statistical Analysis
We used a log-binomial generalized linear mixed model (GLMM) to determine the associations
between maternal Vitamin D levels and allergic diseases. Analysis was performed for the 380
mother–child pairs with complete data for three follow-ups. Pregnant women with deficient Vitamin
D levels were considered as the “exposed” group, while those with nondeficient Vitamin D levels
were considered as the “unexposed” group. Study sites and respondents were entered as random
effects. Multivariable models were adjusted for potential confounding variables significantly associated
with maternal Vitamin D levels and allergic outcomes (p < 0.05) identified from univariable models:
ethnicity, gestational age at birth, mode of delivery, and antibiotic use in infants during the first year of
life. We also performed multivariable models by adjusting additional confounding factors based on
conceptual justification as suggested in previous literature [28]: maternal age, ethnicity, educational
level, household income, work status, parity, antibiotic use during pregnancy, family history of allergic
disease, gestational age at birth, infant birth weight, mode of delivery, sex, number of siblings, pet
keeping, daycare attendance, antibiotic use in infants during the first year, and exclusive breastfeeding
≥ 6 months. All models were adjusted for gestational age at blood withdrawal and eczema status.
Risk ratios (RRs) with a 95% confidence interval (CI) were calculated as the measure of associations
between maternal Vitamin D levels and allergic diseases. Statistical analyses were performed using
IBM SPSS Statistics 22 software (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Characteristics of the Mother–Child Pairs
Of the 535 pregnant women who consented and completed baseline data at the third trimester,
430 mother–child pairs completed the 3 month follow-up, 406 completed the 6 month follow-up, and
380 completed the 12 month follow-up (Figure 1). The reasons for dropout include respondents who
moved out of the study area and were unable to be contacted (51 mother–child pairs), those unwilling
to continue their participation in the study or had parental worries concerning blood taking of their
child (79 mothers), preterm delivery (21 infants), infant death (2 infants), or having been diagnosed
with acute illness (2 infants).
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Table 1 presents the characteristics of the study respondents. Of the 380 pregnant women, 43.2%
Table 1 presents the characteristics of the study respondents. Of the 380 pregnant women,
were Vitamin D deficient, while 56.8% were nondeficient. Overall, the final cohort of the present study
43.2% were Vitamin D deficient, while 56.8% were nondeficient. Overall, the final cohort of the
is representative of the original cohort as there were no significant differences in the characteristics of
present study is representative of the original cohort as there were no significant differences in the
the respondents in terms of maternal age, ethnicity, educational level, work status, parity, family history
characteristics of the respondents in terms of maternal age, ethnicity, educational level, work status,
of allergic disease, and maternal Vitamin D status during late pregnancy between the mother–child
parity, family history of allergic disease, and maternal Vitamin D status during late pregnancy
pairs who completed the 12 month follow-up (n = 380) and those loss to follow-up (n = 155) except for
between the mother–child pairs who completed the 12 month follow-up (n = 380) and those loss to
with monthly household income.
follow-up (n = 155) except for with monthly household income.
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Table 1. Characteristics of the mother–child pairs.
Total
Characteristics

Maternal 25(OH)D Levels
Deficient <
30 nmol/L
(n = 164)

Nondeficient
≥ 30 nmol/L
(n = 216)

p-Value

0.225
0.952

30.0 ± 4.0
161 (98.2)

30.2 ± 4.3
189 (87.5)

0.591
0.001

126 (81.3)

0.824

129 (78.7)

183 (84.7)

0.127

52 (13.7)
209 (55.0)
119 (31.3)

40 (25.8)
72 (46.5)
43 (27.7)

0.003

26 (15.9)
97 (59.1)
41 (25.0)

26 (12.0)
112 (51.9)
78 (36.1)

0.062

267 (70.3)

103 (66.5)

0.387

118 (72.0)

149 (69.0)

0.530

226 (59.5)

83 (53.5)

0.208

101 (61.6)

125 (57.9)

0.465

257 (67.6)

98 (63.2)

0.328

109 (66.5)

148 (68.5)

0.672

44 (11.6)

6 (12.0) a

0.930

37 (22.6)

56 (25.9)

0.450

93 (24.5)

−

−

13 (7.9)

31 (14.4)

0.053

38.9 ± 1.1
3.1 ± 0.4
278 (73.2)
190 (50.0)
226 (59.5)
207 (54.5)
224 (58.9)

38.8 ± 1.0 a
3.1 ± 0.4 a
36 (72.0) a
31 (62.0) a
83 (53.5)
−
−

0.579
0.845
0.862
0.110
0.208
−
−

38.8 ± 1.1
3.1 ± 0.4
119 (72.6)
77 (47.0)
101 (61.6)
82 (50.0)
93 (56.7)

38.9 ± 1.2
3.1 ± 0.4
159 (73.6)
113 (52.3)
125 (57.9)
125 (57.9)
131 (60.6)

0.867
0.620
0.819
0.300
0.465
0.127
0.439

177 (46.6)

13 (50.0) b

0.735

74 (45.1)

103 (47.7)

0.620

Included in Age
12 Month
Analysis (n = 380)

Loss to
Follow-Up
(n = 155)

164 (43.2)
216 (56.8)

63 (40.6)
92 (59.4)

0.594

32 (29, 36)

31 (28–35)

0.013

30.1 ± 4.2
350 (92.1)

29.6 ± 4.0
143 (92.3)

312 (82.1)

Maternal 25(OH)D levels
Deficient (<30 nmol/L)
Nondeficient (≥30 nmol/L)
Gestational age at blood
withdrawal (weeks)
Median (IQR)
Family characteristics
Maternal age (years)
Maternal ethnicity, Malay (%)
Maternal educational level,
higher (%)
Monthly household income
Low (< RM 2300)
Moderate (RM 2300–5599)
High (≥RM 5600)
Maternal work status, working
(%)
Parity, multiparous (%)
Family history of allergic
disease, yes (%)
Maternal antibiotics use during
pregnancy, yes (%)
Pet keeping, yes (%)
Infant characteristics
Gestational age at birth (weeks)
Birth weight (kg)
Mode of delivery, vaginal (%)
Sex, male (%)
Older siblings, yes (%)
Daycare attendance, yes (%)
Antibiotic use, yes (%)
Exclusive breastfeeding till
6 months (%)

p-Value

Data shown are the mean ± standard deviation for the continuous variables and number (percentage) of respondents
for categorical variables. p-values for difference were determined by a Chi-square test for categorical variables
and an independent t-test for two independent samples. RM, Ringgit Malaysia (1 USD = RM 4.28, as of June 23,
2020). a Data available for 50 mother–child pairs who completed the 3 month follow-up. b Data available for 26
mother–child pairs who completed the 6 month follow-up.

3.2. Allergic Outcomes in Infants
Of the 380 infants, 27.6% developed eczema and 6.1% developed wheeze, respectively, during the
first year of life (Table 2). Of the 314 infants who undertook the allergen-specific IgE test at 12 months
of age, 27.4% were sensitized to at least one of the food allergens tested and 10.8% were sensitized to at
least one of the inhalant allergens tested. The top three food allergens sensitized by infants at 12 months
of age were beef (14.3%), peanut (10.8%), and egg white (7.0%), while the top three inhalant allergens
were Dermatophagoides farinae (6.4%), Dermatophagoides pteronyssinus (5.4%), and Blomia tropicalis (4.1%).
The prevalence of IgE-mediated food allergy was 3.8%, with 3.2% egg allergy, 1.0% cow’s milk allergy,
0.6% wheat allergy, and 0.3% soy allergy.
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Table 2. Allergic diseases in infants during the first year of life.
Allergic Diseases

N (%)

Eczema in the past 12 months (n = 380)
Wheeze in the past 12 months (n = 380)
Food sensitization at 12 months (n = 314) 1
Beef (n = 314)
Peanut (n = 314)
Egg white (n = 314)
Egg yolk (n = 314)
Soya (n = 314)
Cow’s milk (n = 314)
Shrimp (n = 314)
Crab (n = 314)
Clam (n = 314)
Codfish (n = 314)
Wheat (n = 314)
Salmon (n = 314)
Chocolate (n = 314)
Rice (n = 314)
Tuna (n = 314)
Chicken (n = 314)
Orange (n = 314)
Inhalant allergen sensitization at 12 months (n = 314) 1
Dermatophagoides farinae (n = 314)
Dermatophagoides pteronyssinus (n = 314)
Blomia tropicalis (n = 314)
Candida (n = 314)
Cat dander (n = 314)
House dust (n = 314)
Dog dander (n = 314)
Cockroach mix (n = 314)
Penicillium (n = 314)
Cladosporium (n = 314)
Aspergillus (n = 314)
Bermuda grass (n = 314)
IgE-mediated food allergy at 12 months (n = 314)
Eggs (n = 314)
Cow’s milk (n = 314)
Wheat (n = 314)
Soy (n = 314)

105 (27.6)
23 (6.1)
86 (27.4)
45 (14.3)
34 (10.8)
22 (7.0)
10 (3.2)
14 (4.5)
7 (2.2)
6 (1.9)
6 (1.9)
4 (1.3)
4 (1.3)
4 (1.3)
3 (1.0)
2 (0.6)
2 (0.6)
2 (0.6)
1 (0.3)
1 (0.3)
34 (10.8)
20 (6.4)
17 (5.4)
13 (4.1)
7 (2.2)
7 (2.2)
6 (1.9)
4 (1.3)
4 (1.3)
3 (1.0)
2 (0.6)
1 (0.3)
1 (0.3)
12 (3.8)
10 (3.2)
3 (1.0)
2 (0.6)
1 (0.3)

Data shown are the number (percentage) of respondents.

1

Allergens with 0% respondents were not shown.

3.3. Associations between Maternal Vitamin D Levels and Allergic Diseases
Table 3 shows the associations of maternal Vitamin D levels with each of the allergic outcomes.
We observed no associations of maternal Vitamin D deficient in late pregnancy with any of the allergic
outcomes in infants during the first year of life, compared with the nondeficient group. These null
associations remained after adjustment for potential confounding factors.
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Table 3. Associations between maternal 25(OH)D levels and allergic diseases in infants during the first
year of life.
Allergic Outcomes

RR (95% CI)
Eczema (n = 380)
Nondeficient (≥30 nmol/L)
Deficient (<30 nmol/L)
Wheeze (n = 380)
Nondeficient (≥30 nmol/L)
Deficient (<30 nmol/L)
Food allergen sensitization (n = 314)
Nondeficient (≥30 nmol/L)
Deficient (<30 nmol/L)
Inhalant allergen sensitization (n = 314)
Nondeficient (≥30 nmol/L)
Deficient (<30 nmol/L)
IgE-mediated food allergy (n = 314)
Nondeficient (≥30 nmol/L)
Deficient (<30 nmol/L)

Adjusted 1

Crude

1
1.02
(0.77–1.35)
1
1.01
(0.48–2.13)
1
1.22
(0.85–1.75)
1
0.58
(0.29–1.16)
1
0.54
(0.18–1.62)

p-Value

0.884

0.973

0.282

0.122

0.269

RR (95% CI)
1
1.04
(0.79–1.38)
1
1.04
(0.50–2.18)
1
1.08
(0.76–1.54)
1
0.58
(0.29–1.15)
1
0.64
(0.30–1.40)

p-Value

0.770

0.915

0.650

0.121

0.268

Adjusted 2
RR (95% CI)
1
1.10
(0.83–1.46)
1
1.10
(0.61–2.00)
1
1.05
(0.75–1.48)
1
0.59
(0.29–1.19)
1
0.68
(0.31–1.53)

p-Value

0.495

0.755

0.782

0.137

0.355

CI, confidence interval; RR, relative risk. 1 Model was adjusted for ethnicity, gestational age at blood withdrawal,
gestational age at birth, mode of delivery, and antibiotic use in infants during the first year. 2 Model was adjusted for
maternal age, ethnicity, educational level, household income, work status, parity, antibiotic use during pregnancy,
gestational age at blood withdrawal, family history of allergic disease, gestational age at birth, infant birth weight,
mode of delivery, sex, number of siblings, pet keeping, daycare attendance, antibiotic use during the first year, and
exclusive breastfeeding ≥ 6 months. Food allergy, wheeze, and allergen sensitization outcomes were adjusted for
eczema status.

4. Discussion
The results of this prospective cohort study suggest that maternal Vitamin D levels in late
pregnancy were not associated with offspring eczema, wheeze, food sensitization, inhalant allergen
sensitization, and IgE-mediated food allergy during the first year of life when adjusted for a range of
potential confounding factors.
The prevalence of infantile eczema (27.6%), wheezing (6.1%), and inhalant allergen sensitization
(10.8%) in the present study is comparable with the parent-reported eczema (20.9%), wheezing (9.8%),
and aeroallergen sensitization (11.2%) in infants at 18 months of age in the Singapore GUSTO cohort
study [29,30]. Similarly, the IgE-mediated food allergy prevalence (3.8%) in the present study is in line
with the prevalence of IgE-mediated food allergy (2.9%) in Singaporean infants aged 12 months [31].
Our study suggests that Malaysian children are at high risk of developing allergies in early life, and
these health issues should be given special attention by health professionals.
Studies that assessed the associations between maternal Vitamin D levels and childhood food
allergy and sensitization reported inconsistent results [10,11,15,32]. The Taiwan PATCH cohort study
found that high maternal Vitamin D levels (≥75 nmol/L) were protective against food sensitization in
children at age 1.5 and 2 years [10]. In contrast, the German LINA cohort study revealed that higher
maternal Vitamin D levels were associated with an increased risk of food allergy and food sensitization
in children at the age of 2 years [11]. In line with our findings, the Cork BASELINE birth cohort and
the GUSTO study found that maternal Vitamin D levels were not associated with childhood food
allergy food sensitization [15,32]. Similar findings were reported in an RCT conducted in the UK that
failed to detect an effect of prenatal Vitamin D supplementation on the risk of food allergy in infants
at 3 years of age [16]. It should be noted that the comparison of findings across studies might be
difficult due to differences in terms of length of follow-up, the period of pregnancy at which maternal
Vitamin D levels were measured, methods of food allergy and food sensitization measurement such
as physician-diagnosed food allergy [11,15], skin prick test [15,32], or specific IgE-confirmed food
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sensitization [10]. In the present study, we did not observe an association between maternal Vitamin D
levels and childhood food allergy, and we therefore speculate that other factors such as genetic factors
may play a more important role in explaining this association. The Boston birth cohort conducted by
Liu et al. [33] showed that cord blood Vitamin D levels were not associated with food sensitization
in early childhood; however, a significant inverse association was found in children with particular
genotypes. Therefore, further studies are needed to explore the interactions between genetic factors
and Vitamin D levels in explaining their relationships with childhood food allergy.
There is lack of consistent findings addressing the associations between maternal Vitamin D levels
and childhood eczema [14,15,32,34]. The inconsistent findings may be explained by the “U-shape”
associations, suggesting that both lower and higher levels of Vitamin D are associated with a higher
risk of eczema [14,34]. The UK birth cohort found that maternal 25(OH)D concentrations > 75 nmol/L
were associated with increased offspring eczema risks at 9 months of age [14]. Another study reported
that mid-pregnancy 25(OH)D concentrations < 25 nmol/L were associated with the increased risk of
eczema in children ≤ 3 years of age [34]. In contrast, we found no associations between maternal
Vitamin D levels and the development of eczema in childhood, which is in line with the findings
reported in the Cork BASELINE birth cohort [15] and the Generation R study [35]. Similarly, results
from several RCTs have not found a protective role of maternal Vitamin D supplementation during
pregnancy in the risk of eczema in infants and children [16–19]. Apart from methodological differences
across studies, the null associations between maternal Vitamin D levels and eczema in the present
study may be explained by genetic factors, which play a more important role in the development of
childhood eczema. Evidence showed that mutations in the filaggrin gene have been strongly associated
with the development of eczema [36,37]. Therefore, the potential for Vitamin D to interact with genetic
factors in explaining the development of childhood eczema should be considered in future studies.
Consistent with previous studies [20,38,39], we found no associations between maternal Vitamin
D levels in late pregnancy and wheeze and inhalant allergen sensitization in infants during the first year
of life. Similarly, findings from several RCTs showed that maternal Vitamin D supplementation during
pregnancy did not pose an effect on the development of wheeze and inhalant allergen sensitization in
infants during the first 3 years of life [16–20]. In contrast to our findings, Rothers et al. [40] reported that
both low (<50 nmol/L) and high (>100 nmol/L) levels of cord blood Vitamin D levels were associated
with increased specific IgE levels with certain inhalant allergens in children at 5 years of age. Another
study demonstrated that low maternal Vitamin D levels (<50 nmol/L) were associated with the higher
risk of aeroallergen sensitization during the first 2 years of life [10]. As findings from the birth cohorts
are inconsistent and previous RCTs failed to demonstrate the protective role of prenatal Vitamin D
supplementation on wheeze and inhalant allergen sensitization in infants, further studies are needed
to determine the combined effects of prenatal and postnatal Vitamin D status on the development of
allergic diseases in offspring.
To the best of knowledge, the present study is the first prospective cohort study to report
the relationship between maternal Vitamin D levels and infants’ allergic outcomes in Malaysia.
The strengths of our study include a longitudinal study design which enables information on a large
number of potential confounders to be recorded and adjusted in multivariable analyses. Parental
reports of allergic outcomes, rather than direct assessment by physicians, are the major limitation of
this study. Previous studies have demonstrated that both lower and higher maternal Vitamin D levels
were associated with an increased risk of allergic diseases in offspring [14,34,40]. In the present study,
we managed to determine the associations between low levels of maternal Vitamin D and infants’
allergic outcomes but were unable to assess the outcomes for high maternal Vitamin D levels due to
low numbers of pregnant women with sufficient Vitamin D levels, which may lead to insufficient
statistical power to detect significant associations with allergic outcomes. Similarly, the low number
of infants with wheeze and IgE-mediated food allergy reported in the present study may lead to
insufficient statistical power to detect their associations with maternal Vitamin D levels. Attrition is
a concern in prospective cohort studies which may lead to selection bias. However, there were no
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significant differences in the majority of the characteristics between the respondents who completed
the study and those loss to follow-up, suggesting limited bias. The present study was able to report
the relationship between low Vitamin D levels in the third trimester pregnant mothers and allergic
disease development in infants from Selangor and Kuala Lumpur—the two most urbanized states in
Malaysia. However, the findings might not be generalizable to the other populations. In the present
study, maternal Vitamin D levels were measured once in late pregnancy, as evidence has shown that
maternal 25(OH)D levels were the highest in late pregnancy and were associated with infants’ serum
25(OH)D [41–43]. However, our study was unable to determine the changes in maternal Vitamin D
levels over the course of pregnancy and their effects on the study outcomes.
5. Conclusions
In conclusion, our results suggest that maternal Vitamin D levels in late pregnancy are not
associated with allergic outcomes in infants during the first year of life. Further studies are needed
to explore the role of Vitamin D in childhood allergies in combination with other environmental and
genetic factors.
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